Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MMP-1 | 103.0 | 65 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | MMP-1 | 142.0 | 57 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MMP-1 | 2249.5 | 34 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | MMP-1 | 5369.0 | 40 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 202.0 | 49 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 377.0 | 71 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 73.0 | 51 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 102.5 | 64 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 620.5 | 50 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 12440.5 | 62 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 4298.0 | 61 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 3248.0 | 46 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 662.0 | 69 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 470.0 | 58 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 22408.5 | 50 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | MMP-1 | 43498.0 | 44 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MMP-1 | 176.0 | 69 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MMP-1 | 1752.5 | 78 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MMP-1 | 67.0 | 60 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MMP-1 | 63.5 | 70 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MMP-1 | 701.0 | 44 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MMP-1 | 17597.0 | 76 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MMP-1 | 1104.0 | 57 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | MMP-1 | 3009.5 | 52 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MMP-1 | 119.0 | 73 |